Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q2 2024 | 1 | -$0.02 | -$0.02 | -$0.02 |
Q3 2024 | 1 | -$0.03 | -$0.02 | -$0.03 |
Q4 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q2 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q3 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
Q4 2025 | 1 | -$0.01 | -$0.00 | -$0.01 |
Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
Xtant Medical Holdings, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.04 earnings per share for the quarter, missing analysts' consensus estimates of $-0.025 by $0.015. The company had revenue of 27.94 M for the quarter and had revenue of 91.30 M for the year. Xtant Medical Holdings, Inc. has generated $0 earnings per share over the last year ($0.0052 diluted earnings per share) and currently has a price-to-earnings ratio of -2.77. Xtant Medical Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.03 | -$0.04 | -0.01 | $29.30 M | $27.94 M |
08/08/2024 | Q2 2024 | -$0.02 | -$0.03 | -0.01 | $28.70 M | $29.94 M |
05/15/2024 | Q1 2024 | -$0.02 | -$0.03 | -0.02 | $27.87 M | |
04/01/2024 | Q4 2023 | -$0.03 | $28.11 M | |||
11/14/2023 | Q3 2023 | $0.07 | $18.90 M | $25.02 M | ||
08/01/2023 | Q2 2023 | -$0.02 | -$0.02 | -0 | $19.50 M | $20.23 M |
05/04/2023 | Q1 2023 | -$0.02 | -$0.02 | -0 | $17.94 M | |
03/07/2023 | Q4 2022 | -$0.02 | $15.27 M | |||
11/03/2022 | Q3 2022 | -$0.03 | $14.46 M | |||
08/04/2022 | Q2 2022 | -$0.02 | $15.28 M | |||
05/05/2022 | Q1 2022 | -$0.03 | $12.96 M | |||
03/08/2022 | Q4 2021 | -$0.03 | $13.97 M | |||
11/12/2021 | Q3 2021 | -$0.02 | $13.78 M | |||
08/05/2021 | Q2 2021 | -$0.01 | $14.98 M | |||
05/11/2021 | Q1 2021 | -$0.00 | $12.54 M | |||
02/24/2021 | Q4 2020 | -$0.01 | $14.02 M | |||
10/29/2020 | Q3 2020 | -$0.11 | -$0.10 | 0.01 | $16.04 M | $14.02 M |
08/03/2020 | Q2 2020 | -$0.11 | -$0.19 | -0.08 | $12.22 M | $10.53 M |
05/07/2020 | Q1 2020 | -$0.19 | $14.78 M | |||
03/05/2020 | Q4 2019 | -$0.21 | -$0.12 | 0.09 | $16.96 M |
Xtant Medical Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
The conference call for Xtant Medical Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Xtant Medical Holdings, Inc.'s latest earnings report can be read online.
Xtant Medical Holdings, Inc. (:XTNT) has a recorded annual revenue of $91.30 M.
Xtant Medical Holdings, Inc. (:XTNT) has a recorded net income of $91.30 M. Xtant Medical Holdings, Inc. has generated $0.0055 earnings per share over the last four quarters.
Xtant Medical Holdings, Inc. (:XTNT) has a price-to-earnings ratio of -2.77 and price/earnings-to-growth ratio is 0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED